Table 2:

Results of the regression analyses evaluating whether thalamic susceptibility is associated with baseline characteristics

Before Adjustment for CovariatesAfter Adjustment for Covariates
Coefficient95% CIP ValueCoefficient95% CIP Value
Presence of enhancing lesions8.400.41–16.40.04a10.682.28–19.09.013a
Age0.19−0.037–0.42.0990.270.031–0.52.02a
Sex0.75−4.36–5.85.771.45−3.69–6.58.58
Use of disease-modifying therapies−0.57−5.46–4.32.820.44−4.43–5.32.86
Disease duration−0.023−0.33–0.28.88−0.066−0.39–0.26.69